INHIBITORS FOR LEPB OF MYCOBACTERIUM TUBERCULOSIS H37RV

Journal Title: World Journal of Pharmaceutical and Medical Research - Year 2019, Vol 5, Issue 4

Abstract

Tuberculosis caused by Mycobacterium tuberculosis is under an urgent need for developing new drug with new target and action, as most available drugs are ineffective due to development of drug resistance at different levels. QSAR model was built and validated to find suitable ligands for inhibition of strategic target in M. tuberculosis. Fifteen molecules were obtained, these are non-mutagenic, non-carcinogenic, non-teratogenic and satisfied the ADME requirements. They docked strongly to the candidate target LepB (Rv2903c)/Spase I, a membrane bound protein. Binding affinities were (-6 to -7.8) kcal/mol, those molecules can be synthesized easily as the synthetic accessibility not exceed 5.5 out of 10.

Authors and Affiliations

Zahra M. Al-Khafaji

Keywords

Related Articles

SCIENTIFIC VIEW OF INFANT DISORDERS ACCORDINGTO CHARAK: A CONCEPTUAL STUDY

Paediatrics is regarded as the medical science which enables an anticipated new born to grow into a healthy adult useful to the society. It is a study of the child from conception through childhood nay adolescence. Breas...

A DETAIL STUDY OF AYURVED CONCEPT OF VRUKKA AND ITS APPLIED ANATOMY

Ayurveda is the oldest surviving complete medical system in the world. Human body through dissection which forms the suitable essential basics and set a strong base for further medical knowledge. In Ayurveda Mutravaha Sa...

STANDARDIZATION OF ZIZIPHUS JUJUBE FRUIT (JUJUBE)

This paper presents studies on the standardization of local raw materials - the fruits of jujube. Reliable morphological and anatomical features characterizing the authenticity of the raw materials have been determined,...

A STUDY OF VENTILATOR RELATED PNEUMONIA IN THE INTENSIVE CARE UNIT

Objectives: Ventilator-associated pneumonia (VAP) is a significant cause of hospital-related infections, one that must be prevented due to its high morbidity and mortality. The purpose of this study was to evaluate the i...

TUMOUR INFILTRATING LYMPHOCYTES AS A PROGNOSTIC AND PREDICTIVE FACTOR FOR NEOADJUVANT CHEMOTHERAPY IN TRIPLE NEGATIVE BREAST CANCER

Background: Triple negative breast cancer is a subtype of breast cancer that shows minimal or no immunohistochemical expression of estrogens receptor, progesterone receptor and human epidermal growth factor receptor 2 (H...

Download PDF file
  • EP ID EP675461
  • DOI -
  • Views 185
  • Downloads 0

How To Cite

Zahra M. Al-Khafaji (2019). INHIBITORS FOR LEPB OF MYCOBACTERIUM TUBERCULOSIS H37RV. World Journal of Pharmaceutical and Medical Research, 5(4), 42-50. https://europub.co.uk./articles/-A-675461